Particle.news

Download on the App Store

Randomized Trial Finds Online Group Singing Improves Quality of Life in COPD and ILD

Presented at the European Respiratory Society Congress, the SINFONIA trial spotlights a feasible remote therapy now drawing calls for replication and integration.

Overview

  • Researchers enrolled 101 adults in Australia with chronic breathlessness from COPD or interstitial lung disease, randomizing 50 to a 12‑week, therapist‑led Zoom singing program and 51 to usual care.
  • Participants in the singing arm reported SF‑36 scores averaging 7.4 points higher than controls, with an 11‑point advantage for those attending at least eight sessions, which investigators called clinically important.
  • Signals of greater benefit emerged for women, people with anxiety or depression, and those who had not previously completed pulmonary rehabilitation.
  • The sessions combined warmups, breathing exercises, group singing and social check‑ins, and the study reduced access barriers by loaning iPads and providing data plans.
  • External experts and patient advocates said the results support non‑drug adjuncts to care and urged further trials to clarify mechanisms and pathways to embed singing programs in services.